Zyban (Anti-Smoking) | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Zyban (Anti-Smoking)
Europe

PharmaCompass Sponsored Ads

Contact Supplier

Bupropion Hydrochloride

Contact Supplier

pharmacompass-1-m-2026-01-12

PharmaCompass Sponsored Ads

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

pharmacompass-2-m-2025-11-03

Zyban (Anti-Smoking)

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

79 API Suppliers, 38 USDMF, 13 EU WC, 11 KDMF, 34 NDC API, 38 Listed Suppliers, $ API Reference Price

79 API Suppliers
38 USDMF
13 EU WC
11 KDMF
34 NDC API
38 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

250 FDF Dossiers, 138 FDA Orange Book, 58 Europe, 12 Canada, 2 Australia, 19 South Africa, 21 Listed Dossiers

250 FDF Dossiers
138 FDA Orange Book
58 Europe
12 Canada
2 Australia
19 South Africa
21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 450MG

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG
TABLET, EXTENDED RELEASE;ORAL - 100MG
TABLET, EXTENDED RELEASE;ORAL - 150MG
TABLET, EXTENDED RELEASE;ORAL - 200MG
TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 150MG
TABLET, EXTENDED RELEASE;ORAL - 300MG
TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 17 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Capital Farma, 6 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 35 BASF, 1 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 21 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 45 Controlled & Modified Release, 43 Direct Compression, 40 Solubilizers, 37 Thickeners and Stabilizers, 35 Granulation, 29 Taste Masking, 29 Lubricants & Glidants, 28 Film Formers & Plasticizers, 24 Parenteral, 23 Topical, 19 Chewable & Orodispersible Aids, 17 Disintegrants & Superdisintegrants, 13 Co-Processed Excipients, 11 Emulsifying Agents, 10 Rheology Modifiers, 7 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules

85 Fillers, Diluents & Binders
76 Coating Systems & Additives
45 Controlled & Modified Release
43 Direct Compression
40 Solubilizers
37 Thickeners and Stabilizers
35 Granulation
29 Taste Masking
29 Lubricants & Glidants
28 Film Formers & Plasticizers
24 Parenteral
23 Topical
19 Chewable & Orodispersible Aids
17 Disintegrants & Superdisintegrants
13 Co-Processed Excipients
11 Emulsifying Agents
10 Rheology Modifiers
7 API Stability Enhancers
6 Surfactant & Foaming Agents
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules

DIGITAL CONTENT

97 News #PharmaBuzz

97 News #PharmaBuzz

GLOBAL SALES INFORMATION

58 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 10 Annual Reports

58 US Medicaid Prescriptions
46 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

12 APIs, 2 FDF Dossiers

12 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 26 Health Canada Patents

20 US Patents
26 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 25 Others

4 USP
25 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 61 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

58 All

01 12care4 ApS

02 4Accord Healthcare BV

03 2Accord Healthcare Slu

04 1BB FARMA SRL

05 2Cinfa Laboratories Sa

06 1DOC GENERICI SRL

07 2GLAXOSMITHKLINE SPA

08 6GLAXOSMITHKLINE SpA

09 1GMM FARMA SRL

10 2Generis Farmaceutica S.A.

11 2Glaxo SmithKline Ireland Limited

12 1Glaxo Wellcome UK Limited

13 1Glaxo Wellcome Uk Limited

14 4GlaxoSmithKline AS

15 3Glaxosmithkline Sa

16 2Glaxosmithkline Trading Services Limited

17 2Ideal Trade Links Uab

18 1NM Pharma Limited

19 2NeoFarma Pharmaceuticals Limited

20 3Orexigen Therapeutics Ireland Limited

21 1Orexigen Therapeutics Ireland Limited (1)

22 1Orifarm AS

23 1Ratiopharm Espana Sa

24 1SANDOZ SPA

25 2Sandoz Pharmaceuticals Sa

26 2Sun Pharmaceutical Industries (Europe) Bv

27 1TEVA BV

28 3Teva BV

29 2Teva Bv

30 1Torrent Pharma, Inc.

filter Active Ingredients Reset all filters

58 All

01 18Bupropion

02 23Bupropion Hydrochloride

03 1Bupropion Hydrochloride; Naltrexone Hydrochloride

04 11Bupropion hydrochloride

05 1Bupropion; Naltrexone

06 1Naltrexone Hydrochloride; Bupropion Hydrochloride

07 3Naltrexone Hydrochloride; Bupropion hydrochloride

filter Dosage Form Reset all filters

58 All

01 2Bupropion 150Mg 30 Joined' Oral Use Rp

02 2Bupropion 300Mg 30 Joined' Oral Use Rp

03 1Extended-Release Film Coated Tablet

04 2Extended-Release Tablet

05 1Film Coated Tablet

06 35Modified Release Tablet

07 7Modified Release Tablets

08 1SR TABLET

09 5Tablet

10 2Blank

filter Country Reset all filters

58 All

01 5Estonia

02 13Italy

03 8Malta

04 14Norway

05 16Spain

06 1Sweden

07 1United Kingdom

filter Brand Name Reset all filters

58 All

01 1BUPROPION DOC

02 1BUPROPION SANDOZ

03 1BUPROPION TEVA

04 2Bupropion Accord

05 2Bupropion Cinfa

06 2Bupropion Generis

07 1Bupropion Ratiopharm

08 2Bupropion Sandoz

09 2Bupropion Sun

10 2Bupropion Teva

11 3Bupropion hydrochloride Teva

12 1ELONTRIL

13 8Elontril

14 6Mysimba

15 4Paritdam

16 3WELLBUTRIN

17 2Wellbutrin

18 4Wellbutrin Retard

19 5Wellbutrin Xr

20 3Zyban

21 2Zyntabac

22 1Blank

List of Suppliers

Product Main Page

01

BB FARMA SRL

IPPE

Not Confirmed

BB FARMA SRL

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : WELLBUTRIN

Dosage Form : Modified Release Tablets

Dosage Strength : 150 mg

Packaging : 30 UNITS 150 MG MODIFIED RELEASE - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

DOC GENERICI SRL

IPPE

Not Confirmed

DOC GENERICI SRL

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : BUPROPION DOC

Dosage Form : Modified Release Tablets

Dosage Strength : 150 mg

Packaging : 30 UNITS 150 MG MODIFIED RELEASE - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Wellbutrin

Dosage Form : Bupropion 150Mg 30 Joined' Oral Use Rp

Dosage Strength : 30 CPR 150 mg modified release bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Elontril

Dosage Form : Bupropion 150Mg 30 Joined' Oral Use Rp

Dosage Strength : 30 CPR 150 mg modified release bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Wellbutrin

Dosage Form : Bupropion 300Mg 30 Joined' Oral Use Rp

Dosage Strength : 30 CPR 300 mg modified release bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Elontril

Dosage Form : Bupropion 300Mg 30 Joined' Oral Use Rp

Dosage Strength : 30 CPR 300 mg modified release bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Zyban

Dosage Form :

Dosage Strength : 100 Cpr 150 Mg Prolonged Release

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

GLAXOSMITHKLINE SpA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Zyban

Dosage Form :

Dosage Strength : 50 Cpr 150 Mg Prolonged Release

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

GLAXOSMITHKLINE SPA

IPPE

Not Confirmed

GLAXOSMITHKLINE SPA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : ELONTRIL

Dosage Form : Modified Release Tablets

Dosage Strength : 150 mg

Packaging : 30 UNITS 150 MG MODIFIED RELEASE - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Torrent Pharma, Inc.

IPPE

Not Confirmed

Torrent Pharma, Inc.

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Generic

Registration Country : United Kingdom

Brand Name :

Dosage Form : SR TABLET

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : United Kingdom

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.